Remnant lipoproteins as therapeutic targets

Atherogenesis: a postprandial phenomenon.

Zilversmit, D. B. (1979) · Circulation · doi:10.1161/01.cir.60.3.473 · Cited by 1,701 · see citing works

Plasma cholesteryl ester transfer protein

Tall, A. (1993) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)36957-1 · Cited by 953 · see citing works

Plasminogen-Activator Inhibitor Type 1 and Coronary Artery Disease

Kohler, H. P., & Grant, P. J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006153422406 · Cited by 805 · see citing works

Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti apo B-100 and anti apo A-I immunoaffinity mixed gels

Nakajima, K., SAITO, T., Tamura, A., Suzuki, M., Nakano, T., Adachi, M., Tanaka, A., Tada, N., Nakamura, H., Campos, E. M., et al. (1993) · Clinica Chimica Acta · doi:10.1016/0009-8981(93)90062-9 · Cited by 417 · see citing works

Apoprotein composition of very low density lipoproteins of human serum.

Kane, J. P., Sata, T., Hamilton, R. L., & Havel, R. J. (1975) · Journal of Clinical Investigation · doi:10.1172/jci108245 · Cited by 376 · see citing works

Postprandial lipoprotein metabolism and atherosclerosis.

Karpe, F. (1999) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1999.00548.x · Cited by 360 · see citing works

Characterization of subfractions of triglyceride-rich lipoproteins separated by gel chromatography from blood plasma of normolipemic and hyperlipemic humans

Sata, T., Havel, R. J., & Jones, A. L. (1972) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39346-9 · Cited by 359 · see citing works

Relation of Lipoprotein Subclasses as Measured by Proton Nuclear Magnetic Resonance Spectroscopy to Coronary Artery Disease

Freedman, D. S., Otvos, J. D., Jeyarajah, E. J., Barboriak, J. J., Anderson, A. J., & Walker, J. A. (1998) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.18.7.1046 · Cited by 345 · see citing works

Characterization of remnants produced during the metabolism of triglyceride-rich lipoproteins of blood plasma and intestinal lymph in the rat.

Mjøs, O. D., Færgeman, O., Hamilton, R. L., & Havel, R. J. (1975) · Journal of Clinical Investigation · doi:10.1172/jci108130 · Cited by 322 · see citing works

Remnant Lipoprotein Levels in Fasting Serum Predict Coronary Events in Patients With Coronary Artery Disease

Kugiyama, K., Doi, H., Takazoe, K., Kawano, H., Soejima, H., Mizuno, Y., Tsunoda, R., Sakamoto, T., Nakano, T., Nakajima, K., et al. (1999) · Circulation · doi:10.1161/01.cir.99.22.2858 · Cited by 284 · see citing works

Relationships between the responses of triglyceride-rich lipoproteins in blood plasma containing apolipoproteins B-48 and B-100 to a fat-containing meal in normolipidemic humans.

Schneeman, B. O., Kotite, L., Todd, K., & Havel, R. J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.2069 · Cited by 255 · see citing works

Characterization of human very low density lipoproteins containing two electrophoretic populations: double pre-beta lipoproteinemia and primary dysbetalipoproteinemia

Pagnan, A., Havel, R. J., Kane, J. P., & Kotite, L. (1977) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41603-7 · Cited by 236 · see citing works

Primary Dysbetalipoproteinemia: Predominance of a Specific Apoprotein Species in Triglyceride-Rich Lipoproteins

Havel, R. J., & Kane, J. P. (1973) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.70.7.2015 · Cited by 231 · see citing works

Atherogenicity of Triglyceride-Rich Lipoproteins

Krauss, R. M. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00032-0 · Cited by 227 · see citing works

Postprandial hyperlipidemia and remnant lipoproteins.

Havel, R. J. (1994) · Current Opinion in Lipidology · doi:10.1097/00041433-199404000-00006 · Cited by 209 · see citing works

Secretion-capture role for apolipoprotein E in remnant lipoprotein metabolism involving cell surface heparan sulfate proteoglycans.

Ji, Z. S., Fazio, S., Lee, Y. L., & Mahley, R. W. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42009-6 · Cited by 209 · see citing works

Quantitative studies of transfer in vivo of low density, Sf 12-60, and Sf 60-400 lipoproteins between plasma and arterial intima in humans.

Shaikh, M., Wootton, R., Nordestgaard, B. G., Baskerville, P., Lumley, J. S., La Ville, A. E., Quiney, J., & Lewis, B. (1991) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.11.3.569 · Cited by 206 · see citing works

Rationale for Use of Non–High-Density Lipoprotein Cholesterol Rather Than Low-Density Lipoprotein Cholesterol as a Tool for Lipoprotein Cholesterol Screening and Assessment of Risk and Therapy

Frost, P. H., & Havel, R. J. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00034-4 · Cited by 193 · see citing works

Association of Remnant Lipoprotein Levels With Impairment of Endothelium-Dependent Vasomotor Function in Human Coronary Arteries

Kugiyama, K., Doi, H., Motoyama, T., Soejima, H., Misumi, K., Kawano, H., Nakagawa, O., Yoshimura, M., Ogawa, H., Matsumura, T., et al. (1998) · Circulation · doi:10.1161/01.cir.97.25.2519 · Cited by 187 · see citing works

Accumulation of large very low density lipoprotein in plasma during intravenous infusion of a chylomicron-like triglyceride emulsion reflects competition for a common lipolytic pathway.

Bjorkegren, J., Packard, C. J., Hamsten, A., Bedford, D., Caslake, M., Foster, L., Shepherd, J., Stewart, P., & Karpe, F. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37637-9 · Cited by 187 · see citing works

Properties of an apolipoprotein E-enriched fraction of triglyceride-rich lipoproteins isolated from human blood plasma with a monoclonal antibody to apolipoprotein B-100.

Campos, E. M., Nakajima, K., Tanaka, A., & Havel, R. (1992) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41527-5 · Cited by 185 · see citing works

The Role of Triglyceride-Rich Lipoprotein Families in the Progression of Atherosclerotic Lesions as Determined by Sequential Coronary Angiography From a Controlled Clinical Trial

Alaupovic, P., Mack, W. J., Knight‐Gibson, C., & Hodis, H. N. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.4.715 · Cited by 184 · see citing works

Lipoprotein clearance mechanisms in LDL receptor-deficient "Apo-B48-only" and "Apo-B100-only" mice.

Véniant, M. M., Zlot, C. H., Walzem, R. L., Pierotti, V., Driscoll, R. M., Dichek, D. A., Herz, J., & Young, S. G. (1998) · Journal of Clinical Investigation · doi:10.1172/jci4164 · Cited by 151 · see citing works

Triglyceride-Rich Lipoprotein Remnant Particles and Risk of Atherosclerosis

Hodis, H. N. (1999) · Circulation · doi:10.1161/01.cir.99.22.2852 · Cited by 149 · see citing works

Remnants of chylomicron and very low density lipoprotein impair endothelium-dependent vasorelaxation

Doi, H., Kugiyama, K., Ohgushi, M., Sugiyama, S., Matsumura, T., Ohta, Y., Nakano, T., Nakajima, K., & Yasue, H. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(97)00291-8 · Cited by 121 · see citing works

Evaluation of an immunoseparation method for quantitative measurement of remnant-like particle-cholesterol in serum and plasma

Leary, E. T., Wang, T., Baker, D. J., Cilla, D. D., Zhong, J., Warnick, G. R., Nakajima, K., & Havel, R. J. (1998) · Clinical Chemistry · doi:10.1093/clinchem/44.12.2490 · Cited by 110 · see citing works

A macrophage receptor for apolipoprotein B48: Cloning, expression, and atherosclerosis

Brown, M. L., Ramprasad, M. P., Umeda, P. K., Tanaka, A., Kobayashi, Y., Watanabe, T., Shimoyamada, H., Kuo, W.-L., Li, R., Song, R., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.120184097 · Cited by 109 · see citing works

Susceptibility to atherosclerosis in mice expressing exclusively apolipoprotein B48 or apolipoprotein B100.

Véniant, M. M., Pierotti, V, Newland, D., Cham, C. M., Sanan, D. A., Walzem, R. L., & Young, S. G. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119511 · Cited by 100 · see citing works

Initial hepatic removal of chylomicron remnants is unaffected but endocytosis is delayed in mice lacking the low density lipoprotein receptor.

Herz, J., Qiu, S., Oesterle, A., deSilva, H., Shafi, S., & Havel, R. J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.10.4611 · Cited by 98 · see citing works

Differences in postprandial concentrations of very—low-density lipoprotein and chylomicron remnants between normotriglyceridemic and hypertriglyceridemic men with and without coronary heart disease

Karpe, F., Hellénius, M.-L., & Hamsten, A. (1999) · Metabolism · doi:10.1016/s0026-0495(99)90076-8 · Cited by 97 · see citing works

Remnant-like Particle Cholesterol Levels in Patients with Dysbetalipoproteinemia or Coronary Artery Disease

Devaraj, S., Vega, G., Lange, R., Grundy, S. M., & Jialal, I. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00089-8 · Cited by 94 · see citing works

Book Review Comprehensive Clinical Nephrology By Richard J. Johnson and John Feehally. Approximately 700 pp., illustrated. St. Louis, Mosby, 2000. $189. 0-7234-3117-5

Kohler, H. J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006153422419 · Cited by 86 · see citing works

Chylomicron/chylomicron remnant turnover in humans: evidence for margination of chylomicrons and poor conversion of larger to smaller chylomicron remnants

Karpe, F., Olivecrona, T., Hamsten, A., & Hultin, M. (1997) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37219-9 · Cited by 80 · see citing works

Association of plasma triglyceride-rich lipoprotein remnants with coronary atherosclerosis in cases of sudden cardiac death

Takeichi, S., Yukawa, N., Nakajima, Y., Osawa, M., Saito, T., Seto, Y., Nakano, T., Saniabadi, A. R., Adachi, M., Wang, T., et al. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(98)00246-9 · Cited by 79 · see citing works

Uptake of Remnant Like Particles (RLP) in Diabetic Patients from Mouse Peritoneal Macrophages

Tomono, S., Kawazu, S., Kato, N., Ono, T., Ishii, C., Ito, Y., Shimizu, M., Shimoyama, M., Nakano, T., & Nakajima, K. (1994) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat1994.1.98 · Cited by 76 · see citing works

Echolucent Carotid Artery Plaques Are Associated With Elevated Levels of Fasting and Postprandial Triglyceride-Rich Lipoproteins

Grønholdt, M.-L. M., Nordestgaard, B. G., Nielsen, T. G., & Sillesen, H. H. (1996) · Stroke · doi:10.1161/01.str.27.12.2166 · Cited by 74 · see citing works

Differences in apolipoprotein and lipid composition between human chylomicron remnants and very low density lipoproteins isolated from fasting and postprandial plasma

Björkegren, J., Karpe, F., Milne, R. W., & Hamsten, A. (1998) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32522-0 · Cited by 72 · see citing works

Improvement of endothelial vasomotor dysfunction by treatment with alpha-tocopherol in patients with high remnant lipoproteins levels

Kugiyama, K., Motoyama, T., Doi, H., Kawano, H., Hirai, N., Soejima, H., Miyao, Y., Takazoe, K., Moriyama, Y., Mizuno, Y., et al. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00057-1 · Cited by 70 · see citing works

Influence of Diets Rich in Saturated and Omega-6 Polyunsaturated Fatty Acids on the Postprandial Responses of Apolipoproteins B-48, B-100, E, and Lipids in Triglyceride-Rich Lipoproteins

Bergeron, N., & Havel, R. J. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.12.2111 · Cited by 70 · see citing works

Accumulation of Apolipoprotein C-I–Rich and Cholesterol-Rich VLDL Remnants During Exaggerated Postprandial Triglyceridemia in Normolipidemic Patients With Coronary Artery Disease

Björkegren, J., Boquist, S., Samnegård, A., Lundman, P., Tornvall, P., Ericsson, C.-G., & Hamsten, A. (2000) · Circulation · doi:10.1161/01.cir.101.3.227 · Cited by 70 · see citing works

Apolipoprotein B-48 or Its Apolipoprotein B-100 Equivalent Mediates the Binding of Triglyceride-Rich Lipoproteins to Their Unique Human Monocyte-Macrophage Receptor

Gianturco, S. H., Ramprasad, M. P., Song, R., Li, R., Brown, M. L., & Bradley, W. A. (1998) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.18.6.968 · Cited by 70 · see citing works

Measurement of human apolipoprotein B-48 and B-100 kinetics in triglyceride-rich lipoproteins using [5,5,5-2H3]leucine.

Lichtenstein, A. H., Hachey, D., Millar, J., Jenner, J., Booth, L., Ordovás, J. M., & Schaefer, E. J. (1992) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41516-0 · Cited by 67 · see citing works

Effect of Statins on Metabolism of Apo-B–Containing Lipoproteins in Hypertriglyceridemic Men

Vega, G. L., & Grundy, S. M. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00036-8 · Cited by 63 · see citing works

Distinct murine macrophage receptor pathway for human triglyceride-rich lipoproteins.

Gianturco, S. H., Lin, A. H., Hwang, S. L., Young, J. B., Brown, S. A., Via, D. P., & Bradley, W. A. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113775 · Cited by 63 · see citing works

Fasting Remnant Lipoprotein Cholesterol and Triglyceride Concentrations Are Elevated in Nondiabetic, Insulin-Resistant, Female Volunteers

Abbasi, F., McLaughlin, T., Lamendola, C. A., Yeni-Komshian, H., Tanaka, A., Wang, T., Nakajima, K., & Reaven, G. M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.11.6136 · Cited by 61 · see citing works

Characterization of remnant-like particles isolated by immunoaffinity gel from the plasma of type III and type IV hyperlipoproteinemic patients

Marcoux, C., Tremblay, M., Nakajima, K., Davignon, J., & Cohn, J. S. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32142-8 · Cited by 61 · see citing works

Plasma remnant-like particle lipid and apolipoprotein levels in normolipidemic and hyperlipidemic subjects

Marcoux, C., Tremblay, M., Fredenrich, A., Jacques, H., Krimbou, L., Nakajima, K., Davignon, J., & Cohn, J. S. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(98)00042-2 · Cited by 57 · see citing works

Membrane Active Lipids in Remnant Lipoproteins Cause Impairment of Endothelium-Dependent Vasorelaxation

Doi, H., Kugiyama, K., Ohgushi, M., Sugiyama, S., Matsumura, T., Ohta, Y., Oka, H., Ogata, N., Hirata, A., Yamamoto, Y., et al. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.8.1918 · Cited by 54 · see citing works

Plasma Lipoproteins Enhance Tissue Factor–Independent Factor VII Activation

Kjalke, M., Silveira, A. M. V., Hamsten, A., Hedner, U. K. E., & Ezban, M. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.7.1835 · Cited by 53 · see citing works

Impaired endothelium-dependent acetylcholine-induced coronary artery relaxation in patients with high serum remnant lipoprotein particles

Inoue, T., Saniabadi, A. R., Matsunaga, R., Hoshi, K., Yaguchi, I., & Morooka, S. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(98)00098-7 · Cited by 50 · see citing works

Ratio of remnant-like particle-cholesterol to serum total triglycerides is an effective alternative to ultracentrifugal and electrophoretic methods in the diagnosis of familial type III hyperlipoproteinemia.

Wang, T., Nakajima, K., Leary, E. T., Warnick, G. R., Cohn, J. S., Hopkins, P. N., Wu, L. L., Cilla, D. D., Zhong, J., & Havel, R. J. (1999) · PubMed · Cited by 45 · see citing works

Remnant-like lipoproteins stimulate whole blood platelet aggregation in vitro

Knöfler, R., Nakano, T., Nakajima, K., Takada, Y., & Takada, A. (1995) · Thrombosis Research · doi:10.1016/0049-3848(95)00044-5 · Cited by 41 · see citing works

Association of remnant-like particle cholesterol with coronary artery disease in patients with normal total cholesterol levels

Masuoka, H., Kamei, S., Wagayama, H., Ozaki, M., Kawasaki, A., Tanaka, T., Kitamura, M., Katoh, S., Shintani, U., Misaki, M., et al. (2000) · American Heart Journal · doi:10.1016/s0002-8703(00)90240-0 · Cited by 40 · see citing works

Remnant-like Particle-Cholesterol Concentrations in Patients with Type 2 Diabetes Mellitus and End-Stage Renal Disease

Hirany, S. V., O’Byrne, D., Devaraj, S., & Jialal, I. (2000) · Clinical Chemistry · doi:10.1093/clinchem/46.5.667 · Cited by 39 · see citing works

Predictive value of remnant-like particles cholesterol/high-density lipoprotein cholesterol ratio as a new indicator of coronary artery disease

Masuoka, H., Ishikura, K., Kamei, S., Obe, T., Seko, T., Okuda, K., Koyabu, S., Tsuneoka, K., Tamai, T., Sugawa, M., et al. (1998) · American Heart Journal · doi:10.1053/hj.1998.v136.89586 · Cited by 33 · see citing works

An increase of serum remnant-like particles in non-insulin-dependent diabetic patients with microalbuminuria

Shimizu, H., Mori, M., & SAITO, T. (1993) · Clinica Chimica Acta · doi:10.1016/0009-8981(93)90033-z · Cited by 31 · see citing works

IS ATHEROSCLEROSIS EXCLUSIVELY A POSTPRANDIAL PHENOMENON?

Mamo, J. C. L., Yu, K. C., Elsegood, C. L., Smith, D., Vine, D. F., Gennat, H. C., Voevodin, M., & Proctor, S. D. (1997) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1997.tb01822.x · Cited by 28 · see citing works

Post-prandial lipaemia

Kirchmair, R., Ebenbichler, C. F., & Patsch, J. R. (1995) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(95)80081-6 · Cited by 16 · see citing works

Transient triglyceridemia in healthy normolipidemic men increases cellular processing of large very low density lipoproteins by fibroblasts in vitro

Björkegren, J., Karpe, F., Vitols, S., Tornvall, P., & Hamsten, A. (1998) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33903-1 · Cited by 10 · see citing works

Thematic review series: The Pathogenesis of Atherosclerosis. Effects of infection and inflammation on lipid and lipoprotein metabolism mechanisms and consequences to the host

Khovidhunkit, W., Kim, M.-S., Memon, R. A., Shigenaga, J. K., Moser, A. H., Feingold, K. R., & Grunfeld, C. (2004) · Journal of Lipid Research · doi:10.1194/jlr.r300019-jlr200 · Cited by 1,481 · see citing works

Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Atherosclerosis Society

Ginsberg, H. N., Packard, C. J., Chapman, M. J., Borén, J., Aguilar-Salinas, C. A., Averna, M., Ference, B. A., Gaudet, D., Hegele, R. A., Kersten, S., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab551 · Cited by 979 · see citing works

Japan Atherosclerosis Society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases 2017

Kinoshita, M., Yokote, K., Arai, H., Iida, M., Ishigaki, Y., Ishibashi, S., Umemoto, S., Egusa, G., Ohmura, H., Okamura, T., et al. (2018) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.gl2017 · Cited by 813 · see citing works

National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 1—Full Report

Jacobson, T. A., Ito, M. K., Maki, K. C., Orringer, C. E., Bays, H. E., Jones, P. H., McKenney, J. M., Grundy, S. M., Gill, E. A., Wild, R. A., et al. (2015) · Journal of clinical lipidology · doi:10.1016/j.jacl.2015.02.003 · Cited by 772 · see citing works

An International Atherosclerosis Society Position Paper: Global recommendations for the management of dyslipidemia

Grundy, S. M. (2013) · Journal of clinical lipidology · doi:10.1016/j.jacl.2013.10.001 · Cited by 349 · see citing works

An International Atherosclerosis Society Position Paper: Global recommendations for the management of dyslipidemia-Full report

Grundy, S. M., Arai, H., Barter, P. J., Bersot, T. P., Betteridge, D. J., Carmena, R., Cuevas, A. M., Davidson, M. H., Genest, J. J., Kesäniemi, Y. A., et al. (2013) · Journal of clinical lipidology · doi:10.1016/j.jacl.2013.12.005 · Cited by 328 · see citing works

Low-Density Lipoprotein, Non-High-Density Lipoprotein, and Apolipoprotein B as Targets of Lipid-Lowering Therapy

Grundy, S. M. (2002) · Circulation · doi:10.1161/01.cir.0000038419.53000.d6 · Cited by 309 · see citing works

Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2022

Okamura, T., Tsukamoto, K., Arai, H., Fujioka, Y., Ishigaki, Y., Koba, S., Ohmura, H., Shoji, T., Yokote, K., Yoshida, H., et al. (2023) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.gl2022 · Cited by 317 · see citing works

Remnant cholesterol as a cause of ischemic heart disease: Evidence, definition, measurement, atherogenicity, high risk patients, and present and future treatment

Varbo, A., Benn, M., & Nordestgaard, B. G. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.11.008 · Cited by 251 · see citing works

Apolipoproteins: metabolic role and clinical biochemistry applications

Dominiczak, M. H., & Caslake, M. J. (2011) · Annals of Clinical Biochemistry: International Journal of Laboratory Medicine · doi:10.1258/acb.2011.011111 · Cited by 238 · see citing works

Measurement and meaning of apolipoprotein AI and apolipoprotein B plasma levels

Marcovina, S. M., & Packard, C. J. (2006) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2006.01648.x · Cited by 180 · see citing works

Postprandial lipoprotein metabolism: VLDL vs chylomicrons

Nakajima, K., Nakano, T., Tokita, Y., Nagamine, T., Inazu, A., Kobayashi, J., Mabuchi, H., Stanhope, K. L., Havel, P. J., Okazaki, M., et al. (2011) · Clinica Chimica Acta · doi:10.1016/j.cca.2011.04.018 · Cited by 168 · see citing works

Dyslipidemia, Kidney Disease, and Cardiovascular Disease in Diabetic Patients

Chen, S.-C., & Tseng, C. (2013) · The Review of Diabetic Studies · doi:10.1900/rds.2013.10.88 · Cited by 152 · see citing works

Approach to lipoprotein management in 2001 National Cholesterol Guidelines

Grundy, S. M. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02631-0 · Cited by 128 · see citing works

Oxidized fat in the diet, postprandial lipaemia and cardiovascular disease

Cohn, J. S. (2002) · Current Opinion in Lipidology · doi:10.1097/00041433-200202000-00004 · Cited by 119 · see citing works

Fenofibrate Effect on Triglyceride and Postprandial Response of Apolipoprotein A5 Variants

Lai, C., Arnett, D. K., Corella, D., Straka, R. J., Tsai, M. Y., Peacock, J. M., Adiconis, X., Parnell, L. D., Hixson, J. E., Province, M. A., et al. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.140103 · Cited by 119 · see citing works

Overexpression of Lipoprotein Lipase in Transgenic Rabbits Inhibits Diet-induced Hypercholesterolemia and Atherosclerosis

Fan, J., Unoki‐Kubota, H., Kojima, N., Sun, H., Shimoyamada, H., Deng, H., Okazaki, M., Shikama, H., Yamada, N., & Watanabe, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105456200 · Cited by 94 · see citing works

Monogenic Dyslipidemias: Window on Determinants of Plasma Lipoprotein Metabolism

Hegele, R. A. (2001) · The American Journal of Human Genetics · doi:10.1086/324647 · Cited by 93 · see citing works

Remnant lipoproteins: are they equal to or more atherogenic than LDL?

Salinas, C. A. A., & Chapman, M. J. (2020) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000682 · Cited by 87 · see citing works

The contribution of ApoB and ApoA1 measurements to cardiovascular risk assessment

Andrikoula, M., & McDowell, I. F. W. (2007) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2007.00714.x · Cited by 88 · see citing works

Elevated levels of remnant lipoproteins are associated with plasma platelet microparticles in patients with type-2 diabetes mellitus without obstructive coronary artery disease

Koga, H., Sugiyama, S., Kugiyama, K., Fukushima, H., Watanabe, K., Sakamoto, T., Yoshimura, M., Jinnouchi, H., & Ogawa, H. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehi746 · Cited by 87 · see citing works

Predictive value of remnant lipoprotein for cardiovascular events in patients with coronary artery disease after achievement of LDL-cholesterol goals

Nakamura, T., Obata, J.-E., Hirano, M., Kitta, Y., Fujioka, D., Saito, Y., Kawabata, K.-I., Watanabe, K., Watanabe, Y., Mishina, H., et al. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.04.040 · Cited by 83 · see citing works

Effect of apolipoprotein E, peroxisome proliferator-activated receptor alpha and lipoprotein lipase gene mutations on the ability of fenofibrate to improve lipid profiles and reach clinical guideline targets among hypertriglyceridemic patients.

Brisson, D., Ledoux, K., Bossé, Y., St‐Pierre, J., Julien, P., Perron, P., Hudson, T. J., Vohl, M., & Gaudet, D. (2002) · Pharmacogenetics · doi:10.1097/00008571-200206000-00007 · Cited by 74 · see citing works

Exercise Prevents the Accumulation of Triglyceride-Rich Lipoproteins and Their Remnants Seen When Changing to a High-Carbohydrate Diet

Koutsari, C., Karpe, F., Humphreys, S. M., Frayn, K. N., & Hardman, A. E. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq0901.095553 · Cited by 79 · see citing works

Lipids and Atherosclerosis: Lessons Learned from Randomized Controlled Trials of Lipid Lowering and Other Relevant Studies

Kreisberg, R. A., & Oberman, A. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.2.8057 · Cited by 70 · see citing works

Exercise to Reduce Cardiovascular Risk — How Much Is Enough?

Tall, A. R. (2002) · New England Journal of Medicine · doi:10.1056/nejme020117 · Cited by 71 · see citing works

Apolipoprotein B-48

Nakajima, K., Nagamine, T., Fujita, M., Ai, M., Tanaka, A., & Schaefer, E. J. (2014) · Advances in clinical chemistry · doi:10.1016/b978-0-12-800263-6.00003-3 · Cited by 67 · see citing works

Ezetimibe: a selective inhibitor of cholesterol absorption

Catapano, A. L. (2001) · European Heart Journal Supplements · doi:10.1016/s1520-765x(01)90106-3 · Cited by 63 · see citing works

A randomized, double blind, placebo controlled, multicenter clinical trial to assess the efficacy and safety of Emblica officinalis extract in patients with dyslipidemia

Upadya, H., Prabhu, S., Prasad, A., Subramanian, D., Gupta, S. B., & Goel, A. (2019) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-019-2430-y · Cited by 60 · see citing works

Postprandial Hyperlipidemia: Its Pathophysiology, Diagnosis, Atherogenesis, and Treatments

Yanai, H., Adachi, H., Hakoshima, M., & Katsuyama, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241813942 · Cited by 58 · see citing works

Antiatherogenic and Cardioprotective Effects of Black Chokeberry (Aronia melanocarpa) Juice in Aging Rats

Daskalova, E., Delchev, S., Peeva, Y. B., Vladimirova‐Kitova, L., Kratchanova, M. G., Kratchanov, C. G., & Denev, P. N. (2015) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2015/717439 · Cited by 58 · see citing works

Atherogenic postprandial remnant lipoproteins; VLDL remnants as a causal factor in atherosclerosis

Nakajima, K., & Tanaka, A. (2018) · Clinica Chimica Acta · doi:10.1016/j.cca.2017.12.039 · Cited by 53 · see citing works

Postprandial Lipemia and Remnant Lipoproteins

Cohn, J. S. (2006) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2006.07.003 · Cited by 54 · see citing works

Remnant Lipoproteins Are Residual Risk Factor for Future Cardiovascular Events in Patients With Stable Coronary Artery Disease and On-Statin Low-Density Lipoprotein Cholesterol Levels <70 mg/dL

Fujihara, Y., Nakamura, T., Horikoshi, T., Obata, J., Fujioka, D., Watanabe, Y., Watanabe, K., & Kugiyama, K. (2019) · Circulation Journal · doi:10.1253/circj.cj-19-0047 · Cited by 52 · see citing works

Ezetimibe: Its Novel Effects on the Prevention and the Treatment of Cholesterol Gallstones and Nonalcoholic Fatty Liver Disease

de Bari, O., Neuschwander‐Tetri, B. A., Liu, M., Portincasa, P., & Wang, D. Q. ‐. (2011) · Journal of Lipids · doi:10.1155/2012/302847 · Cited by 50 · see citing works

Elevated Remnant Cholesterol is Associated with Adverse Cardiovascular Outcomes in Patients with Acute Coronary Syndrome

Shao, Q., Yang, Z., Wang, Y., Li, Q., Han, K., Liang, J., Shen, H., Liu, X., Zhou, Y., Ma, X., et al. (2022) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.63397 · Cited by 49 · see citing works

Exploitation of Lipid Components by Viral and Host Proteins for Hepatitis C Virus Infection

Moriishi, K., & Matsuura, Y. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00054 · Cited by 42 · see citing works

Apolipoprotein E Polymorphisms and Postprandial Triglyceridemia Before and After Fenofibrate Treatment in the Genetics of Lipid Lowering and Diet Network (GOLDN) Study

Irvin, M. R., Kabagambe, E. K., Tiwari, H. K., Parnell, L. D., Straka, R. J., Tsai, M. Y., Ordovás, J. M., & Arnett, D. K. (2010) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.110.950667 · Cited by 41 · see citing works

Acute effect of orlistat on post‐prandial lipaemia and free fatty acids in overweight patients with Type 2 diabetes mellitus

Tan, K. C. B., Tso, A. W. K., Tam, S., Pang, R. W. C., & Lam, K. S. L. (2002) · Diabetic Medicine · doi:10.1046/j.1464-5491.2002.00823.x · Cited by 41 · see citing works

Plant Stanol Supplementation Decreases Serum Triacylglycerols in Subjects with Overt Hypertriglyceridemia

Theuwissen, E., Plat, J., Kallen, C., van Greevenbroek, M. M. J., & Mensink, R. P. (2009) · Lipids · doi:10.1007/s11745-009-3367-6 · Cited by 39 · see citing works

Association of angiopoietin-like protein 3 with hepatic triglyceride lipase and lipoprotein lipase activities in human plasma

Nakajima, K., Kobayashi, J., Mabuchi, H., Nakano, T., Tokita, Y., Nagamine, T., Imamura, S., Ai, M., Otokozawa, S., & Schaefer, E. J. (2010) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/acb.2010.009307 · Cited by 39 · see citing works

Removal of triacylglycerols from chylomicrons and VLDL by capillary beds: the basis of lipoprotein remnant formation

Karpe, F., Bickerton, A. S. T., Hodson, L., Fielding, B. A., Tan, G. D., & Frayn, K. N. (2007) · Biochemical Society Transactions · doi:10.1042/bst0350472 · Cited by 38 · see citing works

Remnant lipoproteins and atherosclerotic cardiovascular disease

Tada, H., Nohara, A., Inazu, A., Mabuchi, H., & Kawashiri, M.-A. (2019) · Clinica Chimica Acta · doi:10.1016/j.cca.2018.12.014 · Cited by 37 · see citing works

The Chain Length of Dietary Saturated Fatty Acids Affects Human Postprandial Lipemia

Karupaiah, T., Tan, C. H., Chinna, K., & Sundram, K. (2011) · Journal of the American College of Nutrition · doi:10.1080/07315724.2011.10719997 · Cited by 35 · see citing works

Lipid-lowering therapy in diabetes mellitus

Niemeijer-Kanters, S. D. J. M. (2001) · The Netherlands Journal of Medicine · doi:10.1016/s0300-2977(01)00105-x · Cited by 35 · see citing works

High Remnant Lipoprotein Predicts Recurrent Cardiovascular Events on Statin Treatment After Acute Coronary Syndrome

Nguyen, S. V., Nakamura, T., & Kugiyama, K. (2014) · Circulation Journal · doi:10.1253/circj.cj-14-0380 · Cited by 34 · see citing works

Exaggerated postprandial lipaemia and lower post-heparin lipoprotein lipase activity in middle-aged men

Jackson, K. G., KNAPPER-FRANCIS, J. M. E., Morgan, L., WEBB, D. H., Zampelas, A., & Williams, C. M. (2003) · Clinical Science · doi:10.1042/cs20030134 · Cited by 34 · see citing works

Effect of the Probiotic Saccharomyces boulardii on Cholesterol and Lipoprotein Particles in Hypercholesterolemic Adults: A Single-Arm, Open-Label Pilot Study

Ryan, J. J., Hanes, D. A., Schafer, M., Mikolai, J., & Zwickey, H. L. (2015) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2014.0063 · Cited by 34 · see citing works

Methods to assess impaired post‐prandial metabolism and the impact for early detection of cardiovascular disease risk

Su, J. W., Nzekwu, M. M. U., Cabezas, M. C., Redgrave, T. G., & Proctor, S. D. (2009) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2009.02179.x · Cited by 33 · see citing works

Induction of Postprandial Inflammatory Response in Adult Onset Growth Hormone Deficiency Is Related to Plasma Remnant-Like Particle-Cholesterol Concentration

Twickler, T. B., Dallinga‐Thie, G. M., Visseren, F. L. J., de Vries, W. R., Erkelens, D. W., & Koppeschaar, H. P. F. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020470 · Cited by 33 · see citing works

Biology: risk factor modification by OCs and HRT lipids and lipoproteins

Godsland, I. F. (2004) · Maturitas · doi:10.1016/j.maturitas.2003.10.013 · Cited by 33 · see citing works

Effect of remnant-like particle on shear-induced platelet activation and its inhibition by antiplatelet agents

Yamazaki, M., Uchiyama, S., Xiong, Y., Nakano, T., Nakamura, T., & Iwata, M. (2004) · Thrombosis Research · doi:10.1016/j.thromres.2004.08.029 · Cited by 30 · see citing works

Properties of triglyceride-rich and cholesterol-rich lipoproteins in the remnant-like particle fraction of human blood plasma

Campos, E. M., Kotite, L., Blanche, P. J., Mitsugi, Y., Frost, P. H., Masharani, U. B., Krauss, R. M., & Havel, R. J. (2002) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)30142-5 · Cited by 28 · see citing works

Cholesterol esters regulate apoB48 secretion in CaCo2 cells

Pal, S., Allister, E. M., Thomson, A., & Mamo, J. C. L. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(01)00630-x · Cited by 26 · see citing works

Measurement of Serum Low Density Lipoprotein Cholesterol and Triglyceride-Rich Remnant Cholesterol as Independent Predictors of Atherosclerotic Cardiovascular Disease: Possibilities and Limitations

Lütjohann, D., Klör, H., & Stellaard, F. (2023) · Nutrients · doi:10.3390/nu15092202 · Cited by 25 · see citing works

Lipid Metabolism and Health

Moffatt, R. J., & STAMFORD, B. A. (2005) · CRC Press eBooks · doi:10.1201/9781420038422 · Cited by 25 · see citing works

Comparison of various lipid parameters in association of target organ damage: a cohort study

Chi, C., Teliewubai, J., Lu, Y., Fan, X., Yu, S., Xiong, J., Zhou, Y., Ji, H., Zhang, Y., & Xu, Y. (2018) · Lipids in Health and Disease · doi:10.1186/s12944-018-0800-y · Cited by 24 · see citing works

High Plasma Concentration of Remnant Lipoprotein Cholesterol in Obese Children and Adolescents

Choi, Y. J., Jo, Y. E., Kim, Y. K., Ahn, S. M., Jung, S. H., Kim, H. J., Chung, Y., Lee, K. W., & Kim, D. J. (2006) · Diabetes Care · doi:10.2337/dc06-0938 · Cited by 24 · see citing works

Postprandial dyslipidemia after a standardized high-fat meal in BMI-matched healthy individuals, and in subjects with prediabetes or type 2 diabetes

Lim, S. K., Kim, Y. J., Khang, A. R., & Eckel, R. H. (2021) · Clinical Nutrition · doi:10.1016/j.clnu.2021.09.004 · Cited by 23 · see citing works

Lipids: Absorption and Transport

Lichtenstein, A. H., & Jones, P. J. H. (2012) · doi:10.1002/9781119946045.ch9 · Cited by 23 · see citing works

Remnant lipoprotein particles and cardiovascular disease risk

Krauss, R. M., & King, S. M. (2022) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2022.101682 · Cited by 22 · see citing works

Association between different lipid parameters and aortic stiffness

Vallée, A., Lelong, H., Lopez‐Sublet, M., Topouchian, J. A., Safar, M. E., & Blacher, J. (2019) · Journal of Hypertension · doi:10.1097/hjh.0000000000002161 · Cited by 20 · see citing works

Hypothesis: Postprandial remnant lipoproteins are the causal factors that induce the insulin resistance associated with obesity

Nakajima, K., Tokita, Y., & Tanaka, A. (2018) · Clinica Chimica Acta · doi:10.1016/j.cca.2018.06.029 · Cited by 17 · see citing works

Impaired response of VLDL lipid and apoB secretion to endotoxin in the fasted rat liver

Aspichueta, P., Pérez-Agote, B., Pérez, S., Ochoa, B., & Fresnedo, O. (2006) · Journal of Endotoxin Research · doi:10.1177/09680519060120030501 · Cited by 17 · see citing works

Relation between charge-based apolipoprotein B-containing lipoprotein subfractions and remnant-like particle cholesterol levels

Zhang, B., Böttcher, A., Imaizumi, S., Noda, K., Schmitz, G., & Saku, K. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.03.004 · Cited by 16 · see citing works

The murine macrophage apoB-48 receptor gene (Apob-48r)homology to the human receptor

Brown, M. L., Yui, K., Smith, J. D., LeBoeuf, R. C., Weng, W., Umeda, P. K., Li, R., Song, R., Gianturco, S. H., & Bradley, W. A. (2002) · Journal of Lipid Research · doi:10.1194/jlr.m100395-jlr200 · Cited by 16 · see citing works

Short-Term Effect of Pitavastatin Treatment on Glucose and Lipid Metabolism and Oxidative Stress in Fasting and Postprandial State Using a Test Meal in Japanese Men

Kakuda, H., Kobayashi, J., Nakato, M., & Takekoshi, N. (2013) · Cholesterol · doi:10.1155/2013/314170 · Cited by 15 · see citing works

Postprandial remnant lipoproteins as targets for the prevention of atherosclerosis

Nakajima, K., & Tanaka, A. (2018) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000393 · Cited by 14 · see citing works

Effects of treatment with Sandostatin®LAR®on small dense LDL and remnant‐like lipoproteins in patients with acromegaly

Tan, K. C. B., Pang, R. W. C., Tiu, S. C., & Lam, K. S. L. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01849.x · Cited by 14 · see citing works

Effects of Moderate Chronic Food Restriction on the Development of Postprandial Dyslipidemia with Ageing

Fernández, A., Mazuecos, L., Pintado, C., Rubio, B., López, V., Solís, A. J. D., Rodríguez-Pérez, M., Andrés, A., & Gallardo, N. (2019) · Nutrients · doi:10.3390/nu11081865 · Cited by 13 · see citing works

Non‐High‐Density Lipoprotein Cholesterol: Why Lower Is Better

Garg, R., Vasamreddy, C. R., & Blumenthal, R. S. (2005) · Preventive Cardiology · doi:10.1111/j.1520-037x.2005.4077.x · Cited by 12 · see citing works

Charge-based heterogeneity of human plasma lipoproteins at hypertriglyceridemia: capillary isotachophoresis study

Dergunov, A. D., Hoy, A., Smirnova, E. A., Visvikis‐Siest, S., & Siest, G. (2003) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(02)00359-x · Cited by 13 · see citing works

Remnant Cholesterol is More Strongly Associated with Arterial Stiffness than Traditional Lipids and Lipid Ratios in the General Chinese Population

Li, B., Zhou, X. J., Liu, Y., Zhang, Y., & Mu, Y. (2023) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.64146 · Cited by 12 · see citing works

Lipoprotein lipase does not increase significantly in the postprandial plasma

Ishiyama, N., Sakamaki, K., Shimomura, Y., Kotani, K., Tsuzaki, K., Sakane, N., Miyashita, K., Fukamachi, I., Kobayashi, J., Stanhope, K. L., et al. (2016) · Clinica Chimica Acta · doi:10.1016/j.cca.2016.11.035 · Cited by 12 · see citing works

Changes in serum triglycerides and high-density lipoprotein concentration and composition after a low-fat mixed meal. Effects of gender and insulin resistance

Branchi, A., Torri, A., Berra, C., Colombo, E., & Sommariva, D. (2006) · Internal and Emergency Medicine · doi:10.1007/bf02934762 · Cited by 11 · see citing works

Saturated Fat and Cardiovascular Disease: A Review of Current Evidence

O'Keeffe, M. M., & St‐Onge, M. (2013) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-013-0295-z · Cited by 9 · see citing works

New Therapeutic Alternatives for the Management of Dyslipidemia

Cassagnol, M., Ezzo, D. C., & Patel, P. N. (2013) · Journal of pharmacy and practice · doi:10.1177/0897190013507582 · Cited by 11 · see citing works

Determinants of postprandial triglyceride and remnant-like lipoproteins in type 2 diabetes

Tan, K. C. B., Tso, A. W. K., Ma, O. C. K., Pang, R. W. C., Tam, S., & Lam, K. S. L. (2004) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.504 · Cited by 8 · see citing works

Effect of Dietary Cholesterol and Fat on Cell Cholesterol Transfer to Postprandial Plasma in Hyperlipidemic Men

Sutherland, W. H. F., de Jong, S. A., & Walker, R. J. (2007) · Lipids · doi:10.1007/s11745-007-3101-1 · Cited by 7 · see citing works

Lipids

Jones, P. J. H., & Lichtenstein, A. H. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-66162-1.00004-4 · Cited by 6 · see citing works

Compound Heterozygotes for a Novel Mutation, Apo E1 Nagoya (Arg142Ser) and Apo E2 (Arg158Cys), with Severe Type III Hyperlipoproteinemia and Familial Hypercholesterolemia

Sakuma, N., Hibino, T., Saeki, T., Nagata, T., Sato, T., Okuda, N., Matsunaga, A., & Sasaki, J. (2014) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.21394 · Cited by 6 · see citing works

Non-remnant triglyceride-rich lipoproteins due to lipoprotein lipase deficiency increase atherosclerosis in mice

Cabodevilla, A. G., Izquierdo, M. C., Basu, D., Younis, W., Tirumalasetty, M. B., Miao, Q. R., Nasias, D., Kanter, J. E., Ho, T. W. W., Gjini, J., et al. (2026) · Nature Communications · doi:10.1038/s41467-025-68193-3 · Cited by 5 · see citing works

The diameter of liver sinusoidal fenestrae is not a major determinant of lipoprotein levels and atherosclerosis in cholesterol-fed rabbits

Jacobs, F., Craeyveld, E. V., Feng, Y., & Geest, B. D. (2009) · Cardiovascular Pathology · doi:10.1016/j.carpath.2009.09.002 · Cited by 5 · see citing works

The Effect of Tofogliflozin Treatment on Postprandial Glucose and Lipid Metabolism in Japanese Men With Type 2 Diabetes: A Pilot Study

Kakuda, H., Kobayashi, J., Sakurai, M., Kakuda, M., & Takekoshi, N. (2017) · Journal of Clinical Medicine Research · doi:10.14740/jocmr2806w · Cited by 5 · see citing works

Treatment of type IIb familial combined hyperlipidemia with the combination pravastatin-piperazine sultosilate

Masana, L., Villoria, J., Sust, M., Ros, E., Plana, N., Pérez‐Jiménez, F., Franco, M., Oliván, J., Pintó, X., & Videla, S. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.05.041 · Cited by 5 · see citing works

Remnant Lipoproteins: A Subfraction of Plasma Triglyceride-Rich Lipoproteins Associated with Postprandial Hyperlipidemia

Nakajima, K. (2014) · Clinical & Experimental Thrombosis and Hemostasis · doi:10.14345/ceth.14013 · Cited by 3 · see citing works

The New Molecular Entity Evolocumab, One Kind of PCSK9 Inhibitor, Reduce Plasma Small Size LDL-Cholesterol Levels by Using a New Standardized Method of Measuring LDL Size

Inoue, I., Kubota, R., Yanagi, S., Akita, M., Nakano, T., Katayama, S., Shimada, A., & Noda, M. (2017) · Open Journal of Molecular and Integrative Physiology · doi:10.4236/ojmip.2017.71001 · Cited by 3 · see citing works

Cholesteryl ester transfer protein inhibition and the treatment of metabolic syndrome

Clark, R. W., & Brousseau, M. E. (2005) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2005.05.004 · Cited by 3 · see citing works

Lipid‐Related Factors

Frayn, K. N., & Stanner, S. A. (2005) · doi:10.1002/9780470774663.ch3 · Cited by 3 · see citing works

Disposition of 14C-β-carotene following delivery with autologous triacylglyceride-rich lipoproteins

Dueker, S. R., Vuong, L. T., Faulkner, B. C., Buchholz, B. A., & Vogel, J. S. (2007) · Nuclear Instruments and Methods in Physics Research Section B Beam Interactions with Materials and Atoms · doi:10.1016/j.nimb.2007.01.219 · Cited by 2 · see citing works

Regulation of Lipoprotein Lipase and Plasma Triglyceride in Acute Stress and Inflammation: Remaining Questions and Perspectives

Nishizawa, K., & Seki, R. (2021) · Annals of Biomedical Research · doi:10.61545/abr-4-123 · Cited by 2 · see citing works

Relationship between Childhood and Adolescent Obesity and Remnant Lipoprotein

Choi, Y. J., Jo, Y. E., Kim, Y. K., Ahn, S. M., Baik, S. H., Jung, S. H., Kim, H. J., Chung, Y., Lee, K. W., & Kim, D. J. (2006) · Journal of Korean Endocrine Society · doi:10.3803/jkes.2006.21.4.311 · Cited by 1 · see citing works

Desirable Components of a Screening Lipid Profile

Emerson, J. F. (2003) · Laboratory Medicine · doi:10.1309/hd5y-8pa7-v0gk-ngy9 · Cited by 1 · see citing works

Lipoprotein metabolism and molecular pathogenesis of atherosclerosis

Sakai, N., Nishida, M., Matsuzawa, Y., & Yamashita, S. (2002) · Advances in cell aging and gerontology · doi:10.1016/s1566-3124(02)11026-1

Biochemical Aspects, Laboratory Diagnosis and Follow-Up of High Blood Cholesterol: NCEP ATP III Guidelines

Jovičić, S. Ž. (2008) · Journal of Medical Biochemistry · doi:10.2478/v10011-007-0044-2

Effects of Pitavastatin on Remnant-Like Lipoprotein Particle Cholesterol in Patients with Dyslipidemia: A Randomized Controlled Trial

Domori, T., SAKUMA, N., Saeki, T., Okayama, N., Hibino, T., Nagata, T., Joh, T., Suzuki, S., Yoshikawa, M., Satô, T., et al. (2012) · Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics · doi:10.3999/jscpt.43.375

After chylomicron remnants, what is left?

Luft, F. C. (2004) · Journal of Molecular Medicine · doi:10.1007/s00109-004-0561-0

The high- and low-activity forms of human plasma phospholipid transfer protein (PLTP)

Jänis, M. T. (2006) · STM:n Hallinnonalan avoin julkaisuarkisto (Julkari)

Complexo miointimal das carótidas comum e interna de portadores de esquistossomose mansônica hepatoesplênica: avaliação com eco- Doppler colorido

Guimarães, A. V. (2006)

Pharmacological Treatments of Lipid Abnormalities

Navare, S. M., & Thompson, P. D. (2005) · CRC Press eBooks · doi:10.1201/9781420038422.ch10

Detection, quantification, and characterization of potentially atherogenic triglyceride-rich remnant lipoproteins

Cohn, J. S., Marcoux, C., & Davignon, J. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.10.2474 · Cited by 156 · see citing works

Triglyceride-Rich Lipoproteins as a Source of Proinflammatory Lipids in the Arterial Wall

Öörni, K., Lehti, S., Sjövall, P., & Kovanen, P. T. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666180530094819 · Cited by 28 · see citing works

Triglyceride-rich lipoproteins and remnants: targets for therapy?

Dallinga-Thie, G. M., Kroon, J., Borén, J., & Chapman, M. J. (2016) · Current Cardiology Reports · doi:10.1007/s11886-016-0745-6 · Cited by 90 · see citing works

Remnant Lipoproteins As Strong Key Particles to Atherogenesis

Fujioka, Y., & Ishikawa, Y. (2009) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.e598 · Cited by 146 · see citing works

Keeping remnants in perspective

Borén, J., & Packard, C. J. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab531 · Cited by 26 · see citing works